These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1474 related items for PubMed ID: 10510398

  • 1. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E, Joosten LA, van Den Bersselaar L, Helsen MM, Bakker AC, van Meurs JB, Graham FL, Richards CD, van Den Berg WB.
    J Immunol; 1999 Oct 15; 163(8):4546-56. PubMed ID: 10510398
    [Abstract] [Full Text] [Related]

  • 2. Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation.
    Nabbe KC, van Lent PL, Holthuysen AE, Sloëtjes AW, Koch AE, Radstake TR, van den Berg WB.
    Arthritis Res Ther; 2005 Oct 15; 7(2):R392-401. PubMed ID: 15743487
    [Abstract] [Full Text] [Related]

  • 3. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.
    Arthritis Rheum; 2004 Feb 15; 50(2):650-9. PubMed ID: 14872510
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E.
    Arthritis Rheum; 2005 Oct 15; 52(10):3239-47. PubMed ID: 16200598
    [Abstract] [Full Text] [Related]

  • 5. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
    Grevers LC, van Lent PL, Koenders MI, Walgreen B, Sloetjes AW, Nimmerjahn F, Sjef Verbeek J, van den Berg WB.
    Arthritis Rheum; 2009 Feb 15; 60(2):396-407. PubMed ID: 19180490
    [Abstract] [Full Text] [Related]

  • 6. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL, Hofkens W, Blom AB, Grevers L, Sloetjes A, Takahashi N, van Tits LJ, Vogl T, Roth J, de Winther MP, van den Berg WB.
    Arthritis Rheum; 2009 Oct 15; 60(10):2954-65. PubMed ID: 19790077
    [Abstract] [Full Text] [Related]

  • 7. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
    Singer II, Kawka DW, Bayne EK, Donatelli SA, Weidner JR, Williams HR, Ayala JM, Mumford RA, Lark MW, Glant TT.
    J Clin Invest; 1995 May 15; 95(5):2178-86. PubMed ID: 7537757
    [Abstract] [Full Text] [Related]

  • 8. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
    Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Kolls JK, Joosten LA, van den Berg WB.
    Arthritis Rheum; 2005 Mar 15; 52(3):975-83. PubMed ID: 15751058
    [Abstract] [Full Text] [Related]

  • 9. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
    van de Loo FA, Arntz OJ, van Enckevort FH, van Lent PL, van den Berg WB.
    Arthritis Rheum; 1998 Apr 15; 41(4):634-46. PubMed ID: 9550472
    [Abstract] [Full Text] [Related]

  • 10. Joint inflammation and chondrocyte death become independent of Fcgamma receptor type III by local overexpression of interferon-gamma during immune complex-mediated arthritis.
    Nabbe KC, Boross P, Holthuysen AE, Sloëtjes AW, Kolls JK, Verbeek S, van Lent PL, van Den Berg WB.
    Arthritis Rheum; 2005 Mar 15; 52(3):967-74. PubMed ID: 15751061
    [Abstract] [Full Text] [Related]

  • 11. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegard D, van Den Berg WB.
    J Immunol; 1999 Nov 01; 163(9):5049-55. PubMed ID: 10528210
    [Abstract] [Full Text] [Related]

  • 12. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ, Yu CL, Kishi H, Motoki K, Mao ZB, Muraguchi A.
    Chin Med J (Engl); 2006 Aug 20; 119(16):1365-73. PubMed ID: 16934183
    [Abstract] [Full Text] [Related]

  • 13. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.
    van de Loo AA, Arntz OJ, Bakker AC, van Lent PL, Jacobs MJ, van den Berg WB.
    Am J Pathol; 1995 Jan 20; 146(1):239-49. PubMed ID: 7856731
    [Abstract] [Full Text] [Related]

  • 14. Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis.
    Geurts J, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB, van de Loo FA.
    Gene Ther; 2007 Dec 20; 14(23):1632-8. PubMed ID: 17851546
    [Abstract] [Full Text] [Related]

  • 15. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL, Van De Loo FA, Holthuysen AE, Van Den Bersselaar LA, Vermeer H, Van Den Berg WB.
    J Rheumatol; 1995 Dec 20; 22(12):2250-8. PubMed ID: 8835558
    [Abstract] [Full Text] [Related]

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Dec 20; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
    van de Loo FA, Kuiper S, van Enckevort FH, Arntz OJ, van den Berg WB.
    Am J Pathol; 1997 Jul 20; 151(1):177-91. PubMed ID: 9212744
    [Abstract] [Full Text] [Related]

  • 18. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
    van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J.
    Ann Rheum Dis; 2008 Dec 20; 67(12):1750-8. PubMed ID: 18055478
    [Abstract] [Full Text] [Related]

  • 19. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
    de Hooge AS, van de Loo FA, Bennink MB, Arntz OJ, Fiselier TJ, Franssen MJ, Joosten LA, Van Lent PL, Richards CD, van den Berg WB.
    Arthritis Rheum; 2003 Jun 20; 48(6):1750-61. PubMed ID: 12794844
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI, Marijnissen RJ, Devesa I, Lubberts E, Joosten LA, Roth J, van Lent PL, van de Loo FA, van den Berg WB.
    Arthritis Rheum; 2011 Aug 20; 63(8):2329-39. PubMed ID: 21520013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.